Suchergebnisse - "Breccia, Massimo"

PubPharm (42)

1

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib : 10-year followup of the GIMEMA CML 0307 study

enthalten in: Haematologica | 2022

von Gugliotta, G. | Castagnetti, F. | Breccia, M. | +23

2

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials : a real-life cohort observational study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Stagno, F. | Breccia, M. | Annunziata, M. | +24

3

Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

enthalten in: Annals of hematology | 2021

von Caocci, G. | Mulas, O. | Capodanno, I. | +33

CommentIn: Ann Hematol. 2021 May;100(5):1335-1336. - PMID 33474630

4

Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study

enthalten in: Leukemia | 2021

von Breccia, M. | Pregno, P. | Castagnetti, F. | +13

5

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

enthalten in: Annals of hematology | 2021

von Scalzulli, E. | Caocci, G. | Efficace, F. | +12

6

Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor : a phase 1b study

enthalten in: Leukemia & lymphoma | 2021

von Ottmann, O. | Stegelmann, F. | Breccia, M. | +4

7

Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia : A New Therapeutic Challenge

enthalten in: Journal of clinical medicine | 2021

von Iurlo, A. | Cattaneo, D. | Bucelli, C. | +1

8

Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission : Rationale and Protocol of the Italian Substudy

enthalten in: Frontiers in oncology | 2021

von Borghi, L. | Rosti, G. | Maggi, A. | +23

9

Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

enthalten in: Clinical drug investigation | 2020

von Serrao, A. | Scalzulli, E. | Fiori, L. | +3

10

Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib

enthalten in: Hematological oncology | 2020

von Mulas, O. | Caocci, G. | Annunziata, M. | +30

1
2
3
4
5
Nächster »
[5]